Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Oct. 14, 2024
Major
depressive
disorder
(MDD),
characterized
by
severe
neuropsychiatric
symptoms
and
significant
cognitive
deficits,
continues
to
present
both
etiological
therapeutic
challenges.
However,
the
specific
underlying
mechanisms
targets
remain
unclear.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(2), P. 436 - 436
Published: Jan. 7, 2025
Chronic
pain
is
a
multidimensional
experience
that
not
only
involves
persistent
nociception
but
also
frequently
accompanied
by
significant
emotional
disorders,
such
as
anxiety
and
depression,
which
complicate
its
management
amplify
impact.
This
review
provides
an
in-depth
exploration
of
the
neurobiological
mechanisms
underlying
comorbidity
chronic
disturbances.
Key
areas
focus
include
dysregulation
major
neurotransmitter
systems
(serotonin,
gamma-aminobutyric
acid,
glutamate)
resulting
functional
remodeling
critical
neural
circuits
implicated
in
processing,
regulation,
reward.
Given
contribution
neuroimmune
to
chronicity
mood
we
further
conducted
investigation
into
role
factors,
including
resident
immune
cells,
infiltrating
release
inflammatory
mediators.
discusses
current
therapeutic
strategies,
encompassing
pharmacological
interventions,
neuromodulation,
integrative
approaches,
emphasizes
necessity
targeted
treatments
address
both
components.
Finally,
it
identifies
gaps
understanding
outlines
future
research
directions
aimed
at
elucidating
complex
interplay
between
thereby
laying
foundation
for
more
effective
holistic
treatment
paradigms.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(28)
Published: April 19, 2024
Pain,
a
comorbidity
of
anxiety
disorders,
causes
substantial
clinical,
social,
and
economic
burdens.
Emerging
evidence
suggests
that
propofol,
the
most
commonly
used
general
anesthetic,
may
regulate
psychological
disorders;
however,
its
role
in
pain-associated
is
not
yet
described.
This
study
investigates
therapeutic
potential
single
dose
propofol
(100
mg
kg
ACS Chemical Neuroscience,
Journal Year:
2024,
Volume and Issue:
15(13), P. 2432 - 2444
Published: June 25, 2024
Chronic
neuropathic
pain
and
comorbid
depression
syndrome
(CDS)
is
a
major
worldwide
health
problem
that
affects
the
quality
of
life
patients
imposes
tremendous
socioeconomic
burden.
More
than
half
with
chronic
also
suffer
from
moderate
or
severe
depression.
Due
to
complex
pathogenesis
CDS,
there
are
no
effective
therapeutic
drugs
available.
The
lack
research
on
neural
circuit
mechanisms
CDS
limits
development
treatments.
purpose
this
article
provide
an
overview
various
circuits
involved
in
CDS.
Notably,
activating
some
can
alleviate
and/or
depression,
while
other
exacerbate
these
conditions.
Moreover,
we
discuss
current
emerging
pharmacotherapies
for
such
as
ketamine.
Understanding
may
clues
novel
drug
treatments
improved
management.
Brain Research Bulletin,
Journal Year:
2025,
Volume and Issue:
225, P. 111335 - 111335
Published: April 8, 2025
The
pathogenesis
of
depression
is
fundamentally
linked
to
the
dysregulation
neural
circuit
structure
and
function.
Notably,
medial
prefrontal
cortex
(mPFC)
basolateral
amygdala
(BLA)
are
critical
brain
regions
in
regulation
depression-related
behaviors.
Depressed
rats
exhibited
attenuated
messaging
between
mPFC
BLA,
along
with
abnormally
enhanced
theta
oscillations
BLA
during
execution
an
exploratory
task.
However,
whether
specific
activation
improves
behavior
recovery
mediated
by
mPFC-BLA
circuitry
unknown.
We
modeled
using
chronic
unpredictable
mild
stimulation
(CUMS)
employed
chemogenetic
approaches
selectively
activate
glutamatergic
neurons
depressed
rats.
Through
simultaneous
monitoring
behavioral
patterns
local
field
potentials
(LFPs)
both
open-field
exploration,
we
conducted
comparative
analyses
chemogenetically
activated
sham-stimulated
groups.
Our
investigation
focused
on
oscillation
dynamics,
network
connectivity
strength,
interregional
information
transfer
behavior.
results
demonstrated
that
not
only
ameliorated
deficits
but
also
mPFC-to-BLA
while
attenuating
oscillations.
These
findings
suggest
restoration
flow
may
play
a
crucial
role
improving
behavior,
thereby
revealing
potential
mechanism
underlying
depressive
state
modulation.
The Journal of Headache and Pain,
Journal Year:
2025,
Volume and Issue:
26(1)
Published: April 11, 2025
Clinical
observational
evidence
suggests
a
close
association
between
Trigeminal
Neuralgia
(TN)
and
Mental
disorders
(MDs).
However,
the
causal
relationship
two
remains
unclear.
This
study
aims
to
observe
analyse
associations
depression,
anxiety,
insomnia,
TN
through
clinical
research.
It
also
employs
Mendelian
randomization
(MR)
analysis
verify
potential
genetic
correlation
various
mental
disorders.
offering
new
insights
for
diagnosis,
prevention,
intervention
strategies
TN.
In
cohort
section,
data
were
collected
from
154
patients
with
TN,
all
of
whom
excluded
preoperative
use
psychotropic
drugs
such
as
carbamazepine.
The
PHQ-9,
GAD-7,
ISI
scales
used
assess
symptoms
insomnia.
Multivariable
linear
regression
models
identify
factors
associated
questionnaire
scores,
model
performance
evaluated
by
adjusted
R²,
AIC,
BIC,
p-values.
Patients
significant
positive
preoperatively
followed
up
one-year
after
surgery,
non-parametric
tests
employed
examine
changes
in
disorder
pain
relief.
MR
main
methods
include
Inverse
Variance
Weighted
(IVW),
Egger,
Median,
Simple
Mode,
Mode.
Benjamini-Hochberg
(BH)
method
was
adjust
p
-values
and
control
false
discovery
rate
(FDR).
Subsequent
sensitivity
analyses
involved
Cochran's
Q
test,
MR-Egger
intercept,
MR-pleiotropy
residual
sum
outlier
test
(MR-PRESSO).
Multiple
revealed
that
longer
disease
duration
greater
involvement
trigeminal
branches
consistently
higher
while
demographic
baseline
BNI
scores
showed
no
predictive
value.
indicated
autism
(OR
=
0.697,
95%
CI
[0.494-0.982],
P
0.039),
schizophrenia
0.910,
[0.831-0.997],
0.042),
ADHD
combined
OCD
0.175,
[0.044-0.693],
0.013)
reduced
risk
Conversely,
bipolar
1.249,
[1.016-1.535],
0.034),
depression
2.375,
[1.043-5.409],
anxiety
1.174,
[1.008-1.368],
insomnia
2.036,
[1.074-3.861],
0.029)increased
elevated
1.43,
[1.04-1.96],
1.00305,
[1.00036-1.00549],
0.013),
1.00918,
[1.00236-1.01605],
0.008).
Longer
broader
nerve
independently
increased
severity
depressive,
symptoms,
highlighting
importance
early
And
results
provide
supporting
MDs
contrast
traditional
view
causes
mood
variety
alter
developing
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 16, 2024
AbstractBackground
Although
numerous
studies
have
reported
correlations
between
emotional
disorders
and
neurosurgical
conditions,
their
causal
relationships
is
not
convincing.
Therefore,
we
seek
to
comprehensively
investigate
the
connection
two
using
bidirectional
Mendelian
randomization
studies.
Methods
The
GWAS
aggregated
data
encompassed
17
types
of
diseases
(including
cerebrovascular
diseases,
functional
disorders,
central
nervous
system
neoplasms,
spinal
cord
other
brain
conditions)
3
(anxiety,
mania,
depression),
sourced
from
IEU
FINNGEN.
The
primary
analysis
method
applied
was
inverse
variance-weighted
(IVW)
analysis,
supplemented
by
MR-Egger
weighted
median
methods
ensure
robust
estimates.
A
series
sensitivity
analyses,
including
Cochran’s
Q
test,
regression,
leave-one-out
were
conducted
detect
pleiotropy
or
heterogeneity.
Results
IVW
estimates
indicated
that
trigeminal
neuralgia
significantly
associated
with
risk
mania
(p=0.002,
odds
ratio
[OR]=1.008,
95
%
confidence
interval
[CI]
=
1.003
1.014),
a
higher
genetic
predisposition
congenital
malformations
may
reduce
development
depression
OR=
0.996;
%CI
0.992
0.998)
effect
on
transient
ischemic
attack
(IVW,
P=0.004,
(p=0.004,
OR
4.141;
1.560
10.988).
results
comprehensive
analyses
consistent
main
causality
estimate.
No
heterogeneity
detected
in
our
MR
study.
Conclusions
Our
large-scaled
predispose
patients
while
depression,
particular,
increases
vulnerability
stroke.